Medicare Enrolled

Stella Douros

Ophthalmology · Brooklyn, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
7501 6TH AVE, Brooklyn, NY 11209
7182382336
Registered in NPPES since 2006
NPI: 1649361072 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Douros from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Douros? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Douros

Stella Douros is an ophthalmology specialist in Brooklyn, NY, with 19 years of NPI registration. Based on federal Medicare data, Douros performed 12,294 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Douros received a total of $3,680 from 23 pharmaceutical and/or device companies across 101 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Douros is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 6% volume in NY $3,680 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
12,294
Medicare services
Top 6% in NY for ophthalmology
Not available
Unique patients (not deduplicated)
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
5,940 $29 $58
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,385 $36 $100
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,052 $114 $175
Aflibercept eye injection (Eylea) 518 $691 $1,453
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
481 $105 $499
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
460 $56 $130
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
417 $13 $100
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
376 $32 $125
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
362 $31 $100
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
307 $138 $250
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
302 $127 $300
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
235 $57 $273
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
84 $56 $100
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
79 $78 $100
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
61 $21 $75
Ultrasound scan to determine eye length and lens power
An ultrasound procedure used to measure the length of the eye and calculate the power of the lens.
59 $56 $196
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
56 $498 $879
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
46 $10 $75
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
27 $319 $793
Complex cataract removal with lens implant
A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision.
19 $688 $1,232
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
17 $25 $75
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
11 $85 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.5% high complexity
76.6% medium
23.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,680
Total received (2018-2024)
Avg $526/year across 7 years
Top 26% in NY for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
101
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$634
2023
$387
2022
$500
2021
$208
2020
$352
2019
$1,388
2018
$211

Payments by company (2024)

Genentech USA, Inc.
$175
Harrow Eye, LLC
$123
Apellis Pharmaceuticals, Inc.
$78
Oyster Point Pharma, Inc.
$57
Regeneron Healthcare Solutions, Inc.
$55
Alcon Vision LLC
$40
Tarsus Pharmaceuticals, Inc.
$36
ABBVIE INC.
$25
Astellas Pharma US Inc
$24
Amgen Inc.
$21
Top 3 companies account for 59.3% of 2024 payments
All-time payments by company (2018-2024) ›
ThromboGenics, Inc.
$1,250
Regeneron Healthcare Solutions, Inc.
$489
Novartis Pharmaceuticals Corporation
$302
Genentech USA, Inc.
$232
Apellis Pharmaceuticals, Inc.
$210
Oyster Point Pharma, Inc.
$178
Allergan, Inc.
$145
GE HealthCare
$139
Mallinckrodt Hospital Products Inc.
$133
Harrow Eye, LLC
$123
Alcon Vision LLC
$78
Astellas Pharma US Inc
$75
Aerie Pharmaceuticals, Inc.
$69
Sun Pharmaceutical Industries Inc.
$54
Tarsus Pharmaceuticals, Inc.
$36
Bausch & Lomb Americas Inc.
$34
ABBVIE INC.
$25
Thea Pharma Inc.
$24
Mallinckrodt LLC
$21
Amgen Inc.
$21
Bausch & Lomb, a division of Bausch Health US, LLC
$18
Allergan Inc.
$18
Alimera Sciences, Inc.
$6
Top 3 companies account for 55.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BEPREVE · BromSite (bromfenac ophthalmic solution) 0.075% · Cequa · Clareon · DUREZOL · DURYSTA · EYLEA · EYLEA HD · IYUZEH · Izervay · Jetrea · LUMIGAN · MIEBO · OZURDEX · RESTASIS · RESTASIS MULTIDOSE · Rhopressa · Rocklatan · Simbrinza · Syfovre · TEPEZZA · TRAVATAN Z · TYRVAYA · VABYSMO · VEVYE · Vabysmo · XDEMVY · XIIDRA · rhopressa
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in Brooklyn?
Compare ophthalmologists in the Brooklyn area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
1,291
County median income
$78,548
Nearest hospital to ZIP centroid (approximate)
VA NEW YORK HARBOR HEALTHCARE SYSTEM - BROOKLYN
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Douros is a mixed practice specialist, with above-average Medicare volume (top 6% in NY), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Douros experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Douros performed 5,940 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Douros receive payments from pharmaceutical companies?
Yes. Douros received a total of $3,680 from 23 companies across 101 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Douros's costs compare to other ophthalmologists in Brooklyn?
Douros's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Douros) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →